TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr |
What is the latest Revenue of TORRENT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹9,620 Cr |
Mar2023 | ₹8,508 Cr |
Mar2022 | ₹8,005 Cr |
Mar2021 | ₹7,939 Cr |
Mar2020 | ₹7,673 Cr |
How is Revenue of TORRENT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹9,620 Cr | 13.07 | |
Mar2023 | ₹8,508 Cr | 6.29 | |
Mar2022 | ₹8,005 Cr | 0.82 | |
Mar2021 | ₹7,939 Cr | 3.47 | |
Mar2020 | ₹7,673 Cr | - |
Compare Revenue of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,458.9 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.8% |
6.8% |
25.6% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses